findmyKOL

Tina Shih, MD

Basic profile

University of California, San Francisco

ORCIDNone on fileNPI
RegionSan Francisco, CA · WestSpecialtyNeurologyFocusNeurology
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding2023–2023Why? →

Tina Shih is a Neurology physician affiliated with University of California, San Francisco. OpenAlex indexes 26 publications with 1,704 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
26publications

Distinct works indexed by OpenAlex.

1,704citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 2023–2023

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    95.6%
    Other antiepileptics23.3%
    Levetiracetam51%Topiramate15%Lacosamide10%Keppra8%Briviact5%Epidiolex5%Vimpat4%Topamax2%Xcopri1%
    Part D<11 patients
    Mood Stabilizer22.8%
    Lamotrigine57%Carbamazepine Er17%Lamotrigine Er10%Lamictal7%Lamictal Xr5%Carbatrol2%Tegretol Xr2%
    Part D<11 patients

    + 13 more classes in this area

  • Cardiovascular

    1.4%
    Central alpha-2 Adrenergic Agonist1.1%
    Guanfacine Hcl56%Clonidine Hcl23%Clonidine Hcl Er21%
    Part D<11 patients
    Omega-3 / fibrate0.3%
    Omega-3 Acid Ethyl Esters100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    0.9%
    H2 blocker0.4%
    Famotidine100%
    Part D<11 patients
    Serotonin-3 Receptor Antagonist0.3%
    Ondansetron Odt100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20232023 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”